Implant-associated anaplastic large cell lymphoma of the breast: Insight into a poorly understood disease

Canadian Journal of Plastic Surgery

Volumn 21, Issue 2, 2013, Pages 95-98

  Weathers, William M ^a   Wolfswinkel, Erik M ^a   Hatef, Daniel A ^a   Lee, Edward I ^a   Hollier, Larry H ^a   Brown, Rodger H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anaplastic large cell lymphoma; Breast implant; Lymphoma; Seroma

Indexed keywords

EID: 84878269184     PISSN: 11952199     EISSN: None     Source Type: Journal    
DOI: 10.1177/229255031302100209     Document Type: Article

References (34)

1. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89: 3909-18.
2. Brogi E, Harris NL. Lymphomas of the breast: Pathology and clinical behavior. Semin Oncol 1999;26: 357-64.
3. Cohen PL, Brooks JJ. Lymphomas of the breast. A clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer 1991;67: 1359-69.
4. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29: 1705-12.
5. U.S. Food and Drug Administration, U.S. Department of Health and Human Services. FDA medical device safety communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. Silver Spring, Md: U.S. Food and Drug Administration. January 26, 2011. (Accessed January 1, 2013).
6. De Jong D, Vasmel WLE, De Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300: 2030-5.
7. Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: A systematic review. Plast Reconstr Surg 2011;127: 2141-50.
8. Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: Results from a structured expert consultation process. Plast Reconstr Surg 2011;128: 629-39.
9. Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: A systematic review. Plast Reconstr Surg 2011;127: 2141-50.
10. Jewell M, Spear SL, Largent J, et al. Anaplastic large T-cell lymphoma and breast implants: A review of the literature. Plast Reconstr Surg 2011;128: 651-61.
11. Bengtson B, Brody GS, Brown MH, et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: A consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011;128: 1-7.
12. Spear SL, Rottman SJ, Glicksman C, et al. Late seromas after breast implants: Theory and practice. Plast Reconstr Surg 2012;130: 423-35.
13. Tebbetts JB. Diagnosis and management of seroma following breast augmentation: An update. Plast Reconstr Surg 2011;128: 17-25.
14. Brinton LA, Lubin JH, Burich MC, et al. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 2001;11: 248-56.
15. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006;118: 2854-62.
16. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg 2007;119: 1987-92.
17. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: A review of the epidemiologic evidence through 2008. Plast Reconstr Surg 2009;123: 790-3.
18. Pukkala E, Boice Jr JD, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long-Term Eff Med 2002;12: 271-9.
19. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusionassociated anaplastic large cell lypmhoma of the breast: Time for it to be defined as a distinct clinico-pathological entity. Haematolgica 2010; 95: 1977-9.
20. Miranda RN, Lin L, Talwalkar SS, et al. Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 2009;133: 1383-90.
21. Smith CA, Gruss HJ, Davis T, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993;73: 1349-60.
22. Harris NL, Jaffe ES, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie house, Virginia, November 1997. J Clin Oncol 1999;17: 3835-3849.
23. Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood 2008;111: 5496-504.
24. Ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma layouts systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol 2000;53: 445-50.
25. DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2; 5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996;87: 3437-41.
26. Pittaluga S, Wlodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 1997;151: 343-51.
27. Roden AC, Macon WR, Keeney GL, et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: An indolent T-cell lymphoproliferative disorder. Modern Pathol 2008;21: 455-63.
28. Taylor KO, Webster HR, Prince HM. Anaplastic large cell lymphoma and breast implants: Five Australian cases. Plast Reconstr Surg 2012;129:610e-617e.
29. Carty MJ, Pribaz JJ, Antin JH, et al. A Patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg 2011;128:112e-118e.
30. Gaudet G, Friedberg JW, Weng A, et al. Breast lymphoma associated with breast implants: Two case-reports and a review of the literature. Leuk Lymphom 2002;43: 115-9.
31. Aladily TN, Medeiros JL, Amin MB, et al. Anaplastic large cell lymphoma associated with breast implants: A report of 13 cases. Am J Surg Pathol 2012;36: 1000-8.
32. Brody G, Deapen D, Gill P, Epstein A, Martin S, Elatra W. T-cell non-Hodgkin's anaplastic lymphoma associated with one style of breast implants. AAPS 89th Annual Meeting, San Antonio, March 20 to 23, 2010.
33. Hall-Findlay EJ. Breast implant complication review: Double capsules and late seromas. Plast Reconstr Surg 2011;127: 56-66.
34. Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004;104: 3358-60.